Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

32 ta ish

Ish: Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

  1. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

    Juhani Knuuti, William Wijns, Antti Saraste +83

    MaqolaOchiq kirish201915 iqtibos
    ABI

  2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

    François Mach, Colin Baigent, Alberico L. Catapano +87

    MaqolaOchiq kirish20198 iqtibos
    ABI

  3. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Gregory A. Roth, Degu Abate, Kalkidan Hassen Abate +97

    MaqolaOchiq kirish20187 iqtibos
    ABI

  4. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    Alberico L. Catapano, Ian Graham, Guy De Backer +15

    MaqolaOchiq kirish20166 iqtibos
    ABI

  5. Atherosclerosis

    Peter Libby, Julie E. Buring, Lina Badimón +5

    Sharh maqola20195 iqtibos
    ABI

  6. The Evolving Future of PCSK9 Inhibitors

    Robert S. Rosenson, Robert A. Hegele, Sergio Fazio +1

    Sharh maqolaOchiq kirish20184 iqtibos
    ABI

  7. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

    Kornelia Kotseva, Guy De Backer, Dirk De Bacquer +43

    MaqolaOchiq kirish20193 iqtibos
    ABI

  8. Comprehensive efforts to increase adherence to statin therapy

    Alexander Vonbank, Stefan Agewall, Keld Per Kjeldsen +13

    Maqola20163 iqtibos
    ABI

  9. Fourth universal definition of myocardial infarction (2018)

    Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe +97

    Maqola20183 iqtibos
    ABI

  10. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – Findings from the EUROASPIRE IV survey

    Željko Reiner, Guy De Backer, Zlatko Fras +4

    Maqola20163 iqtibos
    ABI

  11. Nonadherence to statins: individualized intervention strategies outside the pill box

    Peter Lansberg, André Lee, Zhen-Vin Lee +2

    Sharh maqola20183 iqtibos
    ABI

  12. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

    Guy De Backer, Piotr Jankowski, Kornelia Kotseva +76

    Maqola20193 iqtibos
    ABI

  13. EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

    Kausik K. Ray, Bart Molemans, W. Marieke Schoonen +28

    Maqola20203 iqtibos
    ABI

  14. Interventions to improve adherence to lipid-lowering medication

    Mieke van Driel, Michael D. Morledge, Robin Ulep +3

    Sharh maqola20162 iqtibos
    ABI

  15. Determinants of adherence to evidence-based therapy after acute myocardial infarction

    Hatem Hamood, Rola Hamood, Manfred S. Green +1

    Maqola20152 iqtibos
    ABI

  16. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review

    Mary A. De Vera, Vidula Bhole, Lindsay C. Burns +1

    Sharh maqola20142 iqtibos
    ABI

  17. Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction

    Jeppe Nørgaard Rasmussen, Alice Chong, David A. Alter

    Maqola20072 iqtibos
    ABI

  18. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data

    Sudeep Karve, Mario A. Cleves, Mark Helm +3

    Maqola20092 iqtibos
    ABI

  19. Full Coverage for Preventive Medications after Myocardial Infarction

    Niteesh K. Choudhry, Jerry Avorn, Robert J. Glynn +10

    Maqola20112 iqtibos
    ABI

  20. A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases

    Andrew M. Peterson, David P. Nau, Joyce A. Cramer +3

    Maqola20062 iqtibos
    ABI

  21. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective

    Tomas Jernberg, Pål Hasvold, Martin Henriksson +3

    Maqola20152 iqtibos
    ABI

  22. Cluster randomized controlled trial of Delayed Educational Reminders for Long-term Medication Adherence in ST-Elevation Myocardial Infarction (DERLA-STEMI)

    Jon-David Schwalm, Noah Ivers, Madhu K. Natarajan +5

    Maqola20152 iqtibos
    ABI

  23. Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction

    Eleni Rapsomaniki, Marcus Thuresson, Erru Yang +19

    Maqola20162 iqtibos
    ABI

  24. Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials

    Karla Santo, Suzanne Kirkendall, Tracey‐Lea Laba +5

    Sharh maqola20162 iqtibos
    ABI

  25. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems

    Lou Atkins, Jill Francis, Rafat Islam +9

    Maqola20172 iqtibos
    ABI